InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Gelteq Ltd

GELS Clue Score35
Australia Fiscal year ends June CIK 0001920092
$0.48 -2.06% Close, 13 Oct 2026
Alert on the numbers Alert on insider trades
Price $0.48 −64.17% Close, 13 Oct 2026

Closing prices at the end of each trading day, from 29 Oct 2024. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2023Revenue0.1Operating income−3.1Net income−3.5EPS, diluted−0.44Fiscal year 2024Operating income−2.9Net income−3.5EPS, diluted−0.44Fiscal year 2025Revenue0.2Operating income−5.5Net income−6.6EPS, diluted−0.72
FY2023FY2024FY2025
Revenue 0.1 n/a 0.2
Growth
Operating income −3.1 −2.9 −5.5
Net income −3.5 −3.5 −6.6
Growth
EPS, diluted −0.44 −0.44 −0.72
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2023Operating margin−3,885.3%Net margin−4,391.4%Free cash flow margin−2,260.6%Fiscal year 2024Fiscal year 2025Gross margin30.3%Operating margin−3,317.7%Net margin−4,011.9%Free cash flow margin−3,335.3%
FY2023FY2024FY2025
Gross margin n/a n/a 30.3%
Operating margin −3,885.3% n/a −3,317.7%
Net margin −4,391.4% n/a −4,011.9%
Free cash flow margin −2,260.6% n/a −3,335.3%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2023Operating cash flow−1.8Capital expenditure−0.0Free cash flow−1.8Fiscal year 2024Operating cash flow−1.1Capital expenditure−0.0Free cash flow−1.1Fiscal year 2025Operating cash flow−5.5Capital expenditure−0.0Free cash flow−5.5
FY2023FY2024FY2025
Operating cash flow −1.8 −1.1 −5.5
Capital expenditure −0.0 −0.0 −0.0
Free cash flow −1.8 −1.1 −5.5
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash and securitiesTotal debt
Fiscal year 2023Cash and securities0.4Total debt2.5Net cash (debt)−2.1Shareholders’ equity18.7Debt to equity0.13Fiscal year 2024Cash and securities0.0Total debt5.6Net cash (debt)−5.6Shareholders’ equity15.1Debt to equity0.37Fiscal year 2025Cash and securities0.3Total debt4.2Net cash (debt)−3.9Shareholders’ equity15.8Debt to equity0.27
FY2023FY2024FY2025
Cash and securities 0.4 0.0 0.3
Total debt 2.5 5.6 4.2
Net cash (debt) −2.1 −5.6 −3.9
Shareholders’ equity 18.7 15.1 15.8
Debt to equity 0.13 0.37 0.27

In millions of AUD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of AUD, except per-share figures; shares in millions. Fiscal years ending June, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2023 30 Jun 2023 FY2024 30 Jun 2024 FY2025 30 Jun 2025
Operations
−1.8 −1.1 −5.5
Growth
1.2 1.2 1.2
Investment
−0.0 −0.0 −0.0
calc −1.8 −1.1 −5.5
Growth
−0.1 −0.1 −0.7
Financing
2.0 0.8 6.5

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative. Shown in AUD as filed; the screener converts to dollars.